Literature DB >> 17034575

The T cell response to persistent herpes virus infections in common variable immunodeficiency.

M Raeiszadeh1, J Kopycinski, S J Paston, T Diss, M Lowdell, G A D Hardy, A D Hislop, S Workman, A Dodi, V Emery, A D Webster.   

Abstract

We show that at least half of patients with common variable immunodeficiency (CVID) have circulating CD8(+) T cells specific for epitopes derived from cytomegalovirus (CMV) and/or the Epstein-Barr virus (EBV). Compared to healthy age-matched subjects, more CD8(+) T cells in CVID patients were committed to CMV. Despite previous reports of defects in antigen presentation and cellular immunity in CVID, specific CD4(+) and CD8(+) T cells produced interferon (IFN)-gamma after stimulation with CMV peptides, and peripheral blood mononuclear cells secreted perforin in response to these antigens. In CVID patients we found an association between a high percentage of circulating CD8(+) CD57(+) T cells containing perforin, CMV infection and a low CD4/CD8 ratio, suggesting that CMV may have a major role in the T cell abnormalities described previously in this disease. We also show preliminary evidence that CMV contributes to the previously unexplained severe enteropathy that occurs in about 5% of patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034575      PMCID: PMC1942048          DOI: 10.1111/j.1365-2249.2006.03209.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

Review 1.  Molecular and cellular aspects of X-linked agammaglobulinemia.

Authors:  P Sideras; C I Smith
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

2.  Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications.

Authors:  R A Hermaszewski; A D Webster
Journal:  Q J Med       Date:  1993-01

3.  Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus.

Authors:  I M Kidd; J C Fox; D Pillay; H Charman; P D Griffiths; V C Emery
Journal:  Transplantation       Date:  1993-10       Impact factor: 4.939

4.  CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus.

Authors:  E C Wang; P A Moss; P Frodsham; P J Lehner; J I Bell; L K Borysiewicz
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

5.  Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency.

Authors:  J S Jaffe; W Strober; M C Sneller
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

Review 6.  Infectious complications of the primary immunodeficiencies.

Authors:  E R Stiehm; T W Chin; A Haas; A G Peerless
Journal:  Clin Immunol Immunopathol       Date:  1986-07

7.  Common variable immunodeficiency is associated with defective functions of dendritic cells.

Authors:  Jagadeesh Bayry; Sébastien Lacroix-Desmazes; Michel D Kazatchkine; Lionel Galicier; Yves Lepelletier; David Webster; Yves Lévy; Martha M Eibl; Eric Oksenhendler; Olivier Hermine; Srini V Kaveri
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

8.  Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency (CVID).

Authors:  J Farrant; G Spickett; N Matamoros; D Copas; M Hernandez; M North; H Chapel; A D Webster
Journal:  Immunodeficiency       Date:  1994

9.  Studies on the enteropathy associated with primary hypogammaglobulinaemia.

Authors:  K Teahon; A D Webster; A B Price; J Weston; I Bjarnason
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

10.  Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency.

Authors:  P Aukrust; E M Aandahl; B S Skålhegg; I Nordøy; V Hansson; K Taskén; S S Frøland; F Müller
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

View more
  18 in total

1.  Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency.

Authors:  Monica Piquer Gibert; Laia Alsina; María Teresa Giner Muñoz; Ofelia Cruz Martínez; Karen Ruiz Echevarria; Olga Dominguez; Ana María Plaza Martín; Juan I Arostegui; Guillem de Valles; Manel Juan Otero; Maria Anunciacion Martin-Mateos
Journal:  Eur J Pediatr       Date:  2015-03-10       Impact factor: 3.183

Review 2.  Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events.

Authors:  Sara Pereira da Silva; Elena Resnick; Mary Lucas; Jennifer Lortan; Smita Patel; Charlotte Cunningham-Rundles; Kevin Gatter; Qingyan Liu; Elaine S Jaffe; Helen Chapel
Journal:  J Clin Immunol       Date:  2011-07-09       Impact factor: 8.317

3.  Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus.

Authors:  Sayed Mahdi Marashi; Mohammad Raeiszadeh; Sarita Workman; Afsar Rahbar; Cecilia Soderberg-Naucler; Paul Klenerman; Ronnie Chee; A David Webster; Richard S B Milne; Vincent C Emery
Journal:  J Allergy Clin Immunol       Date:  2011-05-04       Impact factor: 10.793

4.  Clonal and constricted T cell repertoire in Common Variable Immune Deficiency.

Authors:  Manish Ramesh; David Hamm; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2015-01-14       Impact factor: 3.969

5.  T-cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency.

Authors:  L M Haveman; J Scherrenburg; L J Maarschalk-Ellerbroek; P D Hoek; R Schuurman; W de Jager; P M Ellerbroek; B J Prakken; D van Baarle; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

6.  T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections.

Authors:  E A L Bateman; L Ayers; R Sadler; M Lucas; C Roberts; A Woods; K Packwood; J Burden; D Harrison; N Kaenzig; M Lee; H M Chapel; B L Ferry
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

7.  Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID).

Authors:  I Chua; R Standish; S Lear; M Harbord; E Eren; M Raeiszadeh; S Workman; D Webster
Journal:  Clin Exp Immunol       Date:  2007-09-05       Impact factor: 4.330

Review 8.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.

Authors:  Helen Chapel; Charlotte Cunningham-Rundles
Journal:  Br J Haematol       Date:  2009-03-30       Impact factor: 6.998

Review 9.  Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.

Authors:  M D Tarzi; S Grigoriadou; S B Carr; L M Kuitert; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

10.  Neuroborreliosis in a horse with common variable immunodeficiency.

Authors:  Heidi L Pecoraro; M Julia B Felippe; Andrew D Miller; Thomas J Divers; Kenneth W Simpson; Kimberly M Guyer; Gerald E Duhamel
Journal:  J Vet Diagn Invest       Date:  2019-01-19       Impact factor: 1.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.